May 24, 2019 Atreca, a preclinical biotech developing immunotherapies for solid tumors, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The Redwood City, CA-based company was founded in 2010 and plans Read More
Program Areas: Global Health
New York Times: In African Villages, These Phones Become Ultrasound Scanners
By Donald G. McNeil Jr. April 15, 2019 BUSHORO, Uganda — Lying on a church pew with his arm over his head, 6-year-old Gordon Andindagaye whimpered a bit — in fear, not pain — as Dr. William A. Cherniak slowly swept Read More
FierceBiotech: Evotec to acquire Gates Foundation-backed Just Biotherapeutics
By Ben Adams May 21, 2019 Biotech-CRO hybrid Evotec is continuing its deals, buys and collaborations strategy with its acquisition of U.S. biologics company Just Biotherapeutics. The German company is spending a small sum, just $90 million, on its latest purchase, Read More
Press Release: Evotec jump-starts biologics with acquisition of Just Biotherapeutics
May 20, 2019 Hamburg, Germany: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) announced today the signing of a definitive agreement under which Evotec will acquire Just Biotherapeutics, Inc. (“Just.Bio”), for up to $ 90 m including potential performance-based Read More
Vedanta Biosciences
Vedanta Biosciences is creating a new class of drugs to modulate the human microbiome. Vedanta is pioneering the rational design of drugs made of defined consortia of bacteria that are essential dwellers of the gut ecosystem that perform critical functions Read More
Lyndra Therapeutics
Lyndra Therapeutics is developing an orally administered dosage form designed to deliver sustained, steady-state release of one or more drugs for up to a week or longer while temporarily residing in the stomach. The foundation invested in the company to Read More
Business Wire: Lyndra Therapeutics Raises $55 Million in Series B Financing
January 29, 2019 WATERTOWN, Mass.–(BUSINESS WIRE)– Lyndra Therapeutics, which is moving toward making daily pills a thing of the past, today announced it has raised $55 million in Series B financing, funds it will use for Phase II clinical trials, Read More
LumiraDx
LumiraDx develops point-of-care diagnostics solutions on a portable, cloud-connected reader using finger-prick blood samples tested on disposable, microfluidic strips. The company is working to achieve lab-quality performance and health-IT integration at point-of–care settings globally. The foundation invested in the company Read More
Business Wire: Vedanta Biosciences Raises $27 Million Series C Financing to Advance Clinical Pipeline of Microbiome-Derived Product Candidates
December 24th, 2018 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived bacteria, today announced that it has raised $27 million in a Series C financing Read More
Butterfly Network
Butterfly has created the world’s first handheld whole body ultrasound system to democratize healthcare and provide global access to medical imaging. The device is critical to the foundation’s vision of an ecosystem where hardware, software, data and expertise come together Read More